09.08.2010 • News

Merck & Co Says U.S. Looking into its Foreign Activities

Merck and Co said in a regulatory filing on Friday that it had received letters from the Department of Justice and U.S. Securities and Exchange Commission requesting information about the company's activities in foreign countries. The drugmaker said it was cooperating with the requests, and that it believes the requests are part of a broader review of pharmaceutical industry practices in foreign countries.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.